Office for National Statistics, Government Buildings, Newport, UK.
Diabetes Research Centre, University of Leicester, Leicester, UK.
BMJ. 2021 Mar 31;372:n693. doi: 10.1136/bmj.n693.
To quantify rates of organ specific dysfunction in individuals with covid-19 after discharge from hospital compared with a matched control group from the general population.
Retrospective cohort study.
NHS hospitals in England.
47 780 individuals (mean age 65, 55% men) in hospital with covid-19 and discharged alive by 31 August 2020, exactly matched to controls from a pool of about 50 million people in England for personal and clinical characteristics from 10 years of electronic health records.
Rates of hospital readmission (or any admission for controls), all cause mortality, and diagnoses of respiratory, cardiovascular, metabolic, kidney, and liver diseases until 30 September 2020. Variations in rate ratios by age, sex, and ethnicity.
Over a mean follow-up of 140 days, nearly a third of individuals who were discharged from hospital after acute covid-19 were readmitted (14 060 of 47 780) and more than 1 in 10 (5875) died after discharge, with these events occurring at rates four and eight times greater, respectively, than in the matched control group. Rates of respiratory disease (P<0.001), diabetes (P<0.001), and cardiovascular disease (P<0.001) were also significantly raised in patients with covid-19, with 770 (95% confidence interval 758 to 783), 127 (122 to 132), and 126 (121 to 131) diagnoses per 1000 person years, respectively. Rate ratios were greater for individuals aged less than 70 than for those aged 70 or older, and in ethnic minority groups compared with the white population, with the largest differences seen for respiratory disease (10.5 (95% confidence interval 9.7 to 11.4) for age less than 70 years 4.6 (4.3 to 4.8) for age ≥70, and 11.4 (9.8 to 13.3) for non-white 5.2 (5.0 to 5.5) for white individuals).
Individuals discharged from hospital after covid-19 had increased rates of multiorgan dysfunction compared with the expected risk in the general population. The increase in risk was not confined to the elderly and was not uniform across ethnicities. The diagnosis, treatment, and prevention of post-covid syndrome requires integrated rather than organ or disease specific approaches, and urgent research is needed to establish the risk factors.
与一般人群中的匹配对照组相比,量化出院后患有 COVID-19 的个体的特定器官功能障碍的发生率。
回顾性队列研究。
英格兰的 NHS 医院。
47780 名(平均年龄 65 岁,55%为男性)因 COVID-19 住院并于 2020 年 8 月 31 日前出院的患者,与来自英格兰约 5000 万人的个人和临床特征 10 年电子健康记录池中的对照组完全匹配。
直至 2020 年 9 月 30 日的住院再入院(或对照组的任何入院)、全因死亡率以及呼吸、心血管、代谢、肾脏和肝脏疾病的诊断率。按年龄、性别和种族划分的率比变化。
在平均 140 天的随访期间,近三分之一出院后患有急性 COVID-19 的个体再次入院(47780 名中有 14060 名),超过 10 分之一(5875 名)在出院后死亡,这些事件的发生率分别比对照组高 4 倍和 8 倍。患有 COVID-19 的患者的呼吸系统疾病(P<0.001)、糖尿病(P<0.001)和心血管疾病(P<0.001)的发生率也明显升高,分别为每 1000 人年 770(95%置信区间 758 至 783)、127(122 至 132)和 126(121 至 131)例。与年龄≥70 岁的个体相比,年龄<70 岁的个体的比率比年龄≥70 岁的个体更高,与白种人相比,少数民族群体的比率比白种人更高,其中呼吸系统疾病的差异最大(<70 岁的年龄组为 10.5(95%置信区间 9.7 至 11.4),≥70 岁的年龄组为 4.6(4.3 至 4.8),非白种人 11.4(9.8 至 13.3),白种人 5.2(5.0 至 5.5))。
与一般人群中的预期风险相比,出院后患有 COVID-19 的个体发生多器官功能障碍的风险增加。这种风险的增加不仅限于老年人,而且在种族之间也不是统一的。COVID-19 后综合征的诊断、治疗和预防需要综合而不是针对器官或疾病的方法,迫切需要开展研究以确定风险因素。